{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:57:09Z","timestamp":1776063429922,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T00:00:00Z","timestamp":1488412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Damon Runyon Foundation","award":["DRR3415"],"award-info":[{"award-number":["DRR3415"]}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["348963"],"award-info":[{"award-number":["348963"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NSF CAREER Award","award":["1351688"],"award-info":[{"award-number":["1351688"]}]},{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand","doi-asserted-by":"publisher","award":["27120"],"award-info":[{"award-number":["27120"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000953","name":"Alliance for Cancer Gene Therapy","doi-asserted-by":"publisher","award":["15051543"],"award-info":[{"award-number":["15051543"]}],"id":[{"id":"10.13039\/100000953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation","doi-asserted-by":"publisher","award":["15082537"],"award-info":[{"award-number":["15082537"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NSF","award":["DGE1322106"],"award-info":[{"award-number":["DGE1322106"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 CA154274"],"award-info":[{"award-number":["T32 CA154274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jconrel.2017.02.034","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T22:38:30Z","timestamp":1488321510000},"page":"151-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells"],"prefix":"10.1016","volume":"263","author":[{"given":"Joshua M.","family":"Gammon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Gosselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa H.","family":"Tostanoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chieh","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangbin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.02.034_bb0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1208\/s12248-014-9708-2","article-title":"Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance","volume":"17","author":"Andorko","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0010","doi-asserted-by":"crossref","first-page":"263ra160","DOI":"10.1126\/scitranslmed.3009980","article-title":"Rational design of small molecules as vaccine adjuvants","volume":"6","author":"Wu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0015","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.4049\/jimmunol.1103143","article-title":"Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells","volume":"188","author":"Waickman","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.it.2014.11.005","article-title":"Regulation of T cells by mTOR: the known knowns and the known unknowns","volume":"36","author":"Pollizzi","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0045","doi-asserted-by":"crossref","first-page":"15421","DOI":"10.18632\/oncotarget.7304","article-title":"Improving the clinical impact of biomaterials in cancer immunotherapy","volume":"7","author":"Gammon","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0055","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells","volume":"115","author":"Gattinoni","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0065","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1158\/1078-0432.CCR-11-0503","article-title":"Determinants of successful CD8(+) T-cell adoptive immunotherapy for large established tumors in mice","volume":"17","author":"Klebanoff","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0070","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/1078-0432.CCR-08-0022","article-title":"Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization","volume":"14","author":"Walker","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/imr.12135","article-title":"Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy","volume":"257","author":"Crompton","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","article-title":"Memory T cell subsets, migration patterns, and tissue residence","volume":"31","author":"Mueller","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/annonc\/mdi113","article-title":"mTOR-targeted therapy of cancer with rapamycin derivatives","volume":"16","author":"Vignot","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1517\/13543784.2013.787066","article-title":"Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer","volume":"22","author":"Nelson","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0095","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26961","article-title":"Immunosuppressants in cancer prevention and therapy","volume":"2","author":"Blagosklonny","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0100","article-title":"Temporal regulation of rapamycin on memory CTL programming by IL-12","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0105","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.1103365","article-title":"Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity","volume":"188","author":"Li","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1158\/2326-6066.CIR-13-0046","article-title":"mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA","volume":"1","author":"Diken","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0115","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1158\/1535-7163.MCT-14-0400","article-title":"Blockade of mTOR signaling via rapamycin combined with immunotherapy augments antiglioma cytotoxic and memory T-cell functions","volume":"13","author":"Mineharu","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0120","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.4049\/jimmunol.175.8.5058","article-title":"Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression","volume":"175","author":"Hiura","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0125","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2015.07.029","article-title":"Single-injection vaccines: progress, challenges, and opportunities","volume":"219","author":"McHugh","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0130","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1073\/pnas.1105200108","article-title":"In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles","volume":"108","author":"Jewell","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0135","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1016\/j.biomaterials.2011.03.067","article-title":"Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy","volume":"32","author":"Kwong","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0145","first-page":"e50984","article-title":"Intra-lymph node injection of biodegradable polymer particles","author":"Andorko","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0150","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","article-title":"Reprogramming the local lymph node microenvironment promotes tolerance that is systemic and antigen specific","volume":"16","author":"Tostanoski","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.actbio.2015.12.026","article-title":"Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradation","volume":"32","author":"Andorko","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12195-016-0455-6","article-title":"targeted programming of the lymph node environment causes evolution of local and systemic immunity","volume":"9","author":"Andorko","year":"2016","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0165","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nbt1154","article-title":"Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy","volume":"23","author":"de Vries","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0170","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1158\/1078-0432.CCR-10-3272","article-title":"Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial","volume":"17","author":"Ribas","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0175","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm.2754","article-title":"Therapies for allergic inflammation: refining strategies to induce tolerance","volume":"18","author":"Akdis","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0180","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaci.2013.07.033","article-title":"Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?","volume":"132","author":"Witten","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2017.02.034_bb0185","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","article-title":"CD5L\/AIM regulates lipid biosynthesis and restrains Th17 Cell pathogenicity","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0190","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","article-title":"A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells","volume":"166","author":"Singer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.02.034_bb0195","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1158\/0008-5472.CAN-15-0454","article-title":"Rapamycin impairs antitumor CD8+ T-cell responses and vaccine-induced tumor eradication","volume":"75","author":"Chaoul","year":"2015","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T19:50:03Z","timestamp":1536004203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917300937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":39,"alternative-id":["S0168365917300937"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.034","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}